Unbiased AI-powered news
2 stories related to this topic, newest first.
themarketherald.com.auA randomized trial examined whether a myostatin inhibitor preserves lean mass during tirzepatide treatment. The study reported 55 percent retention of lean mass compared with placebo.
news.google.comResearch indicates that methods used to maintain astronaut muscle and bone strength in microgravity can inform strategies to mitigate age-related physical decline. These approaches extend beyond increased exercise to include nutritional and environmental factors. The findings dra…